Paralegal Brief

Edwards Lifescience 2021 Proxy Votes

Corporate Governance

APRIL 29, 2021

Edwards Lifescience 2021 annual meeting is May 4, 10 AM Pacific Time. The post Edwards Lifescience 2021 Proxy Votes appeared first on Corporate Governance. To attend, vote, and submit questions during the Annual Meeting visit www.proxydocs.com/EW. They do not make it easy. I had to find the control number […].

Government

Delhi High Court restrains generic pharmaceutical companies from making Novartis patented drug

JURIST

NOVEMBER 3, 2021

The order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech. The court said that the generic companies’ manufacturing or selling of these tablets may amount to infringement of a patent owned by major pharmaceutical company Novartis AG.

Manufacturing

Manufacturing Court Legal Legal

Case of the Day: Genus Lifesciences v. Tapaysa Engineering

LettersBlogatory

MAY 4, 2021

The case of the day is Genus Lifesciences Inc. Tapaysa Eng’g Works Pvt. Genus brought a commercial claim against Tapaysa, an Indian company. It sought to serve process via the Indian central authority but was unsuccessful.

Webinars

Smarter Patent Family Research: The Tools And Tactics You Need Now

Fresh Out of School: How to Become an Expert Paralegal

MORE WEBINARS

Case of the Day: Genus Lifesciences v. Tapaysa Engineering

LettersBlogatory

MAY 4, 2021

The case of the day is Genus Lifesciences Inc. The post Case of the Day: Genus Lifesciences v. Tapaysa Eng’g Works Pvt. Genus brought a commercial claim against Tapaysa, an Indian company. It sought to serve process via the Indian central authority but was unsuccessful. The answer: none.

Court Decisions

Court Decisions Court

Integra Brass Face Investor Suit Over FDA Compliance Lapses

Law 360

MAY 14, 2025

Executives and directors of medical device company Integra Lifesciences Inc. were hit with a derivative suit alleging they misled investors about the company's compliance with regulatory standards for over five years, causing share declines when information regarding Integra's violations emerged.

Edwards Brass Face Investor Suit Over Heart Valve Sales

Law 360

JANUARY 2, 2025

The executives and directors of medical device maker Edwards Lifesciences have been hit with a shareholder derivative suit in California federal court alleging the company understated how industry trends and macroeconomic factors would impact the success of its mainstay device.

Court

Fed. Circ. Told Edwards Safe Harbor IP Suit Was Malicious

Law 360

AUGUST 6, 2024

The Federal Circuit rightfully held Meril Life Sciences was protected by a patent safe harbor when bringing its preapproval transcatheter heart valve system to an industry conference and that Edwards Lifesciences' attempts to prove otherwise are just delay tactics, Meril told the full court.

Court

Edwards Urges Full Fed. Circ. To Limit FDA Safe Harbor

Law 360

MAY 28, 2024

Edwards Lifesciences has petitioned the full Federal Circuit to narrow its interpretation of a U.S. Food and Drug Administration safe harbor that essentially allows patent infringement during drug development, arguing that if Congress wanted the statute to be interpreted broadly, "it would have said exactly that."

Statute

Battle Lines Are Drawn on Noncompete Ban

Intelligize Blog

MAY 2, 2024

Similar comments can be found in recent filings by companies such as Maravai Lifesciences Holdings Inc. By prohibiting noncompete agreements, the FTC has only made the process of hiring and retaining skilled employees more difficult in that regard, according to the biotechnology manufacturer. and FTI Consulting.

Healthcare

Healthcare Contract Manufacturing Lawyer

Apple v. Vidal: APA Compliance in IPR Discretionary Denial Rules

Patently O

AUGUST 20, 2024

Although Apple is the first-named appellant, other parties seeking to overturn the rule include Cisco, Google, Intel, and Edwards LifeSciences. . § 316(a)(2), (4) In my view, the discretionary denial rules are clearly substantive and binding on PTAB judges — putting the district court’s decision likely in the error column.

Court

Rules to Challenge Patents May Loosen Up

The IP Law Blog

APRIL 27, 2023

In 2020, Apple, Cisco, Google, Intel, and Edwards Lifesciences sued the Director of the PTO under the Administrative Procedure Act. In 2022, the Director modified the Fintiv instructions in several respects, including deemphasizing the advanced stage of the litigation.

Litigating

Litigating Litigation Statute Court

Federal Circuit Debates Scope of 271(e)(1) Safe Harbor and the Meaning of “Solely”

Patently O

MARCH 27, 2024

by Dennis Crouch The Federal Circuit’s recent 2-1 decision in Edwards Lifesciences Corp. Integra Lifesciences I, Ltd. , Meril Dispute The case of Edwards Lifesciences Corp. Edwards Lifesciences Corp. Integra Lifesciences I, Ltd. , Meril Life Sciences Pvt. 271(e)(1). ” Merck KGaA v. 193 (2005).

Statute

Statute Manufacturing Court Technology

Pending En Banc Petitions at the Federal Circuit

Patently O

JUNE 12, 2024

DC] Edwards Lifesciences – Expanded 271(e)(1) Safe Harbor : In Edwards Lifesciences Corp. GM, but the court has not issued an en banc decision in a utility patent case since 2018. There are currently four interesting petitions pending before the court. I am no longer involved the litigation. Meril Life Sciences Pvt. ,

Litigating

Litigating Litigation Statute Court

Supreme Court on Patent Law: November 2023

Patently O

NOVEMBER 29, 2023

The petitioners – including Intel, Edwards Lifesciences Corp., and Edwards Lifesciences LLC – brought suit alleging that the Fintiv rule exceeds the PTO’s statutory authority under the America Invents Act (AIA) and is arbitrary and capricious under the Administrative Procedure Act (APA).

Prima Facie Case

Prima Facie Case Court Laws Technology

Safe Harbor at a Crossroads: Examining the Scope of 271(e)(1) in Edwards v. Meril

Patently O

NOVEMBER 19, 2024

by Dennis Crouch The Federal Circuit’s divided ruling in Edwards Lifesciences Corp. Meril Life Sciences is now before the U.S. Supreme Court — focusing on the scope of the Hatch-Waxman Act’s safe harbor provision. At issue is whether 35 U.S.C. §

Manufacturing

Manufacturing Court Laws

Paralegal Brief

Edwards Lifescience 2021 Proxy Votes

Delhi High Court restrains generic pharmaceutical companies from making Novartis patented drug

Webinars

Trending Sources

Case of the Day: Genus Lifesciences v. Tapaysa Engineering

Webinars

Case of the Day: Genus Lifesciences v. Tapaysa Engineering

Integra Brass Face Investor Suit Over FDA Compliance Lapses

Edwards Brass Face Investor Suit Over Heart Valve Sales

Fed. Circ. Told Edwards Safe Harbor IP Suit Was Malicious

Edwards Urges Full Fed. Circ. To Limit FDA Safe Harbor

Battle Lines Are Drawn on Noncompete Ban

Apple v. Vidal: APA Compliance in IPR Discretionary Denial Rules

Rules to Challenge Patents May Loosen Up

Federal Circuit Debates Scope of 271(e)(1) Safe Harbor and the Meaning of “Solely”

Pending En Banc Petitions at the Federal Circuit

Supreme Court on Patent Law: November 2023

Safe Harbor at a Crossroads: Examining the Scope of 271(e)(1) in Edwards v. Meril

Stay Connected